文献速递流行病学与生物统计医学教育与科研方法

已发表的试验方案报告中相关系统评价和随机试验的引用情况

The citation of relevant systematic reviews and randomised trials in published reports of trial protocols.
PubMed 文献 · Trials · 2016-12-07

该研究评估已发表随机对照试验(RCT)方案中引用现有证据以论证试验合理性的情况,纳入2015年12月PubMed索引的101份RCT方案。结果显示,相对较高比例的方案引用了随机试验或系统评价,但仍有部分方案未引用RCT或系统评价未能影响试验设计,需改进以明确试验基于当代最佳证据。

要点

  • 在101份RCT方案中,引用系统评价并补充随机试验者占9.9%,仅引用系统评价者占30.7%。
  • 21.8%的方案仅引用随机试验,17.8%明确以首次解决研究问题作为理由。
  • 10.9%的方案未引用任何RCT,8.9%的方案引用了系统评价但未影响试验设计。

核心结论

  • 相对较高比例的随机试验方案引用了随机试验、系统评价或两者,但仍需改进以确保临床试验的合理性明确并基于当代最佳证据。

研究设计与样本

  • 研究获取了2015年12月一个月内发表于PubMed的随机试验方案,由两名研究者独立双份提取数据,评估引用既往研究(包括相关系统评价和随机试验)的频率。

主要发现

  • 共纳入101份RCT方案,其中平行组设计74份(73.3%)。
  • 引用系统评价并补充随机试验的方案占9.9%(n=10),仅引用系统评价而未补充随机试验者占30.7%(n=31),仅引用随机试验者占21.8%(n=22)。
  • 明确以首次解决研究问题为由论证试验合理性的方案占17.8%(n=18)。
  • 未引用RCT的方案占10.9%(95%CI:5.6,18.7)(n=11)。
  • 引用了系统评价但未影响试验设计的方案占8.9%(95%CI:4.2,16.2)(n=9)。

关键数值与推荐

  • 引用系统评价并补充随机试验:9.9%(n=10)。
  • 仅引用系统评价:30.7%(n=31)。
  • 仅引用随机试验:21.8%(n=22)。
  • 以首次解决研究问题为理由:17.8%(n=18)。
  • 未引用RCT:10.9%(95%CI:5.6,18.7)(n=11)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is important that planned randomised trials are justified and placed in the context of the available evidence. The SPIRIT guidelines for reporting clinical trial protocols recommend that a recent and relevant systematic review should be included. The aim of this study was to assess the use of the existing evidence in order to justify trial conduct. METHODS: Protocols of randomised trials published over a 1-month period (December 2015) indexed in PubMed were obtained. Data on trial characteristics relating to location, design, funding, conflict of interest and type of evidence included for trial justification was extracted in duplicate and independently by two investigators. The frequency of citation of previous research including relevant systematic reviews and randomised trials was assessed. RESULTS: Overall, 101 protocols for RCTs were identified. Most proposed trials were parallel-group (n = 74; 73.3%). Reference to an earlier systematic review with additional randomised trials was found in 9.9% (n = 10) of protocols and without additional trials in 30.7% (n = 31), while reference was made to randomised trials in isolation in 21.8% (n = 22). Explicit justification for the proposed randomised trial on the basis of being the first to address the research question was made in 17.8% (n = 18) of protocols. A randomised controlled trial was not cited in 10.9% (95% CI: 5.6, 18.7) (n = 11), while in 8.9% (95% CI: 4.2, 16.2) (n = 9) of the protocols a systematic review was cited but did not inform trial design. CONCLUSIONS: A relatively high percentage of protocols of randomised trials involves prior citation of randomised trials, systematic reviews or both. However, improvements are required to ensure that it is explicit that clinical trials are justified and shaped by contemporary best evidence.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pandis N, Fleming PS, Koletsi D, et al. The citation of relevant systematic reviews and randomised trials in published reports of trial protocols. Trials. 2016. PMID: 27927219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。